NPI: 1144282393 · HERMISTON, OR 97838 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/04/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/04/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,489 | $259K |
| 2019 | 16,949 | $118K |
| 2020 | 21,436 | $100K |
| 2021 | 23,841 | $78K |
| 2022 | 20,898 | $83K |
| 2023 | 12,398 | $137K |
| 2024 | 5,728 | $162K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 40,719 | 2,218 | $932K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 32,912 | 1,383 | $5K |
| J1756 | Injection, iron sucrose, 1 mg | 7,785 | 1,598 | $390.20 |
| J1270 | Injection, doxercalciferol, 1 mcg | 16,608 | 975 | $130.33 |
| A4657 | Syringe, with or without needle, each | 5,177 | 2,131 | $69.18 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 756 | 397 | $41.02 |
| G0008 | Administration of influenza virus vaccine | 134 | 110 | $0.86 |
| 83970 | 2,367 | 1,440 | $0.33 | |
| 90662 | 12 | 12 | $0.27 | |
| 85041 | 2,252 | 1,341 | $0.10 | |
| 85048 | 2,240 | 1,336 | $0.07 | |
| 83540 | 1,587 | 944 | $0.00 | |
| 82108 | 154 | 87 | $0.00 | |
| 82728 | 1,592 | 955 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 320 | 183 | $0.00 |
| 83550 | 1,280 | 759 | $0.00 | |
| 82746 | 260 | 152 | $0.00 | |
| 82607 | 228 | 139 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 300 | 141 | $0.00 |
| 90674 | 56 | 45 | $0.00 |